Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1648-1654

  Haider, Thomas ^a   Casucci, Gaia ^b   Linser, Tobias ^a   Faulhaber, Martin ^a   Gatterer, Hannes ^a   Ott, Guenter ^c   Linser, Armin ^d   Ehrenbourg, Igor ^e   Tkatchouk, Elena ^e   Burtscher, Martin ^a   Bernardi, Luciano ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF PAVIA   (Italy)

^c Pulmonologist Office   (Austria)

^d Primary Care Physician Office   (Austria)

^e Hypoxia Medical Academy   (Russian Federation)

Author keywords

Autonomic nervous system; Baroreflex sensitivity; Chronic obstructive lung disease; Hypoxia; Intermittent hypoxic training; Ventilatory control

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PROTON PUMP INHIBITOR; THEOPHYLLINE; THYROXINE;

ADULT; AIRFLOW; ARTERIAL OXYGEN SATURATION; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; BREATHING; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR SYSTEM; CHEMORECEPTOR REFLEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; HYPERCAPNIA; HYPEROXIA; HYPOXIA; LUNG FUNCTION; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RESPIRATION CONTROL; TRAINING; TREATMENT DURATION;

EID: 68449092607     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832c0018     Document Type: Article

References (43)

1. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:502-506.
2. Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005; 128:3618-3624.
3. Chhabra SK, De S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med 2005; 99:126-133.
4. Tug T, Terzi SM, Yoldas TK. Relationship between the frequency of autonomie dysfunction and the severity of chronic obstructive pulmonary disease. Acta Neurol Scand 2005; 112:183-188.
5. Patakas D, Louridas G, Kakavelas E. Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease. Thorax 1982; 37:292-295.
6. Volterrani M, Scalvini S, Mazzuero G, Lanfranchi P, Colombo R, Clark AL, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106:1432-1437.
7. Bartels MN, Jelic S, Ngai P, Basner RC, DeMeersman RE. High-frequency modulation of heart rate variability during exercise in patients with COPD. Chest 2003; 124:863-869.
8. Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164:597-601.
9. Altose MD, McCauley WC, Kelsen SG, Cherniack NS. Effects of hypercapnia and inspiratory flow-resistive loading on respiratory activity in chronic airways obstruction. J Clin Invest 1977; 59:500-507.
10. Bradley CA, Fleetham JA, Anthonisen NR. Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis 1979; 120:21-30.
11. Kelsen SG, Fleegler B, Altose MD. The respiratory neuromuscular response to hypoxia, hypercapnia, and obstruction to airflow in asthma. Am Rev Respir Dis 1979; 120:517-527.
12. Hida W. Role of ventilatory drive in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5:339-343.
13. Bartels MN, Gonzalez JM, Kim W, De Meersman RE. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest 2000; 118:691-696.
14. Pfeiffer G, Geyer H, Geyer R, Kalsner I, Wendorf P. Separation of glycoprotein-N-glycans by high-pH anion-exchange chromatography. Biomed Chromatogr 1990; 4:193-199.
15. Fleetham JA, Mezon B, West P, Bradley CA, Anthonisen NR, Kryger MH. Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD. Am Rev Respir Dis 1980; 122:583-589.
16. Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76:536-542.
17. Vos PJ, Folgering HT, van Herwaarden CL. Predictors for nocturnal hypoxaemia (mean SaO2 < 90%) in normoxic and mildly hypoxic patients with COPD. Eur Respir J 1995; 8:74-77.
18. Bernardi L Interval hypoxic training. Adv Exp Med Biol 2001; 502:377-399.
19. Bernardi L, Passino C, Serebrovskaya Z, Serebrovskaya T, Appenzeller O. Respiratory and cardiovascular adaptations to progressive hypoxia; effect of interval hypoxic training. Eur Heart J 2001; 22:879-886.
20. Garcia N, Hopkins SR, Powell FL. Effects of intermittent hypoxia on the isocapnic hypoxic ventilatory response and erythropoiesis in humans. Respir Physiol 2000; 123:39-49.
21. Global Initiative For Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. GOLD Workshop Report; 2001. http://www.goldcopd.com.
22. Serebrovskaya TV. Intermittent hypoxia research in the former Soviet Union and the commonwealth of independent states: history and review of the concept and selected applications. High Alt Med Biol 2002; 3:205-221.
23. Spicuzza L, Gabutti A, Porta C, Montano N, Bernardi L. Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet 2000; 356:1495-1496.
24. Bernardi L, Gabutti A, Porta C, Spicuzza L. Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens 2001; 19:2221-2229.
25. Bernardi L, Hilz M, Stemper B, Passino C, Welsch G, Axelrod FB. Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia. Am J Respir Crit Care Med 2003; 167:141-149.
26. Costes F, Roche F, Pichot V, Vergnon JM, Garet M, Barthelemy JC. Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD. Eur Respir J 2004; 23:396-401.
27. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003; 21:892-905.
28. Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomie nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4:1207-1214.
29. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de BP. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004; 110:1308-1312.
30. Mal H. Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 2007; 13:114-119.
31. Narayan M, Ferranti R. Nerve conduction impairment in patients with respiratory insufficiency and severe chronic hypoxemia. Arch Phys Med Rehabil 1978; 59:188-192.
32. Malik RA, Masson EA, Sharma AK, Lye RH, Ah-See AK, Compton AM, et al. Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 1990; 33:311-318.
33. Hjalmarsen A, Aasebo U, Aleksandersen G, Jorde R. Cardiovascular responses to tests for autonomie dysfunction in patients with chronic obstructive pulmonary disease with and without continuous long-term oxygen therapy. J Auton Nerv Syst 1996; 60:169-174.
34. Fahey PJ, Hyde RW. Won't breathe' vs 'can't breathe'. Detection of depressed ventilatory drive in patients with obstructive pulmonary disease. Chest 1983; 84:19-25.
35. Van de Ven MJ, Colier WN, Van der Sluijs MC, Kersten BT, Oeseburg B, Folgering H. Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients. Eur Respir J 2001; 18:61-68.
36. Levi-Valensi P, Weitzenblum E, Rida Z, Aubry P, Braghiroli A, Donner C, et al. Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. Eur Respir J 1992; 5:301-307.
37. Burtscher M, Pachinger O, Ehrenbourg I, Mitterbauer G, Faulhaber M, Puhringer R, et al. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. Int J Cardiol 2004; 96:247-254.
38. Butcher SJ, Jones RL The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease. Sports Med 2006; 36:307-325.
39. Nici L Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21:693-704.
40. Katayama K, Sato Y, Morotome Y, Shima N, Ishida K, Mori S, et al. Intermittent hypoxia increases ventilation and Sa(O2) during hypoxic exercise and hypoxic chemosensitivity. J Appl Physiol 2001; 90:1431-1440.
41. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166:675-679.
42. Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N. Baroreflex sensitivity in obesity: relationship with cardiac autonomie nervous system activity. Obesity (Silver Spring) 2007; 15:1685-1693.
43. Ge RL, Stone JA, Levine BD, Babb TG. Exaggerated respiratory chemosensitivity and association with SaO2 level at 3568 m in obesity. Respir Physiol Neurobiol 2005; 146:47-54.